These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix. Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H. Gynecol Oncol; 1997 Apr; 65(1):23-9. PubMed ID: 9103386 [Abstract] [Full Text] [Related]
10. p53 gene mutations and MDM2 amplification are uncommon in primary carcinomas of the uterine cervix. Kessis TD, Slebos RJ, Han SM, Shah K, Bosch XF, Muñoz N, Hedrick L, Cho KR. Am J Pathol; 1993 Nov; 143(5):1398-405. PubMed ID: 8238255 [Abstract] [Full Text] [Related]
11. Loss of sequences on the short arm of chromosome 17 is a late event in squamous carcinoma of the cervix. Herrington CS, Worsham M, Southern SA, Mackowiak P, Wolman SR. Mol Pathol; 2001 Jun; 54(3):160-4. PubMed ID: 11376128 [Abstract] [Full Text] [Related]
12. p53 mutation and MDM2 amplification are rare even in human papillomavirus-negative cervical carcinomas. Ikenberg H, Matthay K, Schmitt B, Bauknecht T, Kiechle-Schwarz M, Göppinger A, Pfleiderer A. Cancer; 1995 Jul 01; 76(1):57-66. PubMed ID: 8630877 [Abstract] [Full Text] [Related]
13. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Ferguson AW, Svoboda-Newman SM, Frank TS. Mod Pathol; 1998 Jan 01; 11(1):11-8. PubMed ID: 9556417 [Abstract] [Full Text] [Related]
14. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma]. Zhao W, Si J, Li K. Zhonghua Fu Chan Ke Za Zhi; 1995 Nov 01; 30(11):654-7. PubMed ID: 8745488 [Abstract] [Full Text] [Related]
15. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations. Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M, Taketani Y. Br J Cancer; 1999 Mar 01; 79(7-8):1139-44. PubMed ID: 10098748 [Abstract] [Full Text] [Related]
16. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers. Szarka K, Veress G, Juhász A, Kónya J, Sápy T, Soós G, Hernádi Z, Gergely L. Anticancer Res; 2000 Mar 01; 20(3B):2161-7. PubMed ID: 10928171 [Abstract] [Full Text] [Related]
17. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Löning T. Int J Cancer; 1995 Nov 27; 63(5):639-45. PubMed ID: 7591279 [Abstract] [Full Text] [Related]
18. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India. Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, Shanmugam G. Gynecol Oncol; 1998 Jun 27; 69(3):205-9. PubMed ID: 9648588 [Abstract] [Full Text] [Related]
19. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus. Crook T, Wrede D, Tidy J, Scholefield J, Crawford L, Vousden KH. Oncogene; 1991 Jul 27; 6(7):1251-7. PubMed ID: 1650445 [Abstract] [Full Text] [Related]
20. Pathogenetic significance of p53 and c-Ki-ras gene mutations and human papillomavirus DNA integration in adenocarcinoma of the uterine cervix and uterine isthmus. Jiko K, Tsuda H, Sato S, Hirohashi S. Int J Cancer; 1994 Dec 01; 59(5):601-6. PubMed ID: 7960232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]